IP Verse

Boehringer Ingelheim Vetmedica Gmbh competitive analysis

Latest oppositions filed by Boehringer Ingelheim Vetmedica Gmbh

Explore patent oppositions filed by Boehringer Ingelheim Vetmedica Gmbh against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP3546580
Vectors For Transforming Mycoplasma Hyopneumoniae, Transformed M.Hyopneumoniae Strains, And Use ThereofHIPRA SCIENTIFICJun 3, 2026
EP3842456
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESJun 13, 2025
EP3653645
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESMay 20, 2025
EP4107159
5-(3-(Ethylsulfonyl)Pyridin-2-Yl)-Pyrazolo[1,5-A]Pyrimidine Derivatives And Related Compounds As Pesticide And Insecticide Agents For Crop ProtectionPI INDUSTRIESJan 16, 2025
EP3300743
Methods Of Vaccine AdministrationZOETIS SERVICESMar 13, 2024
EP3733672
Heterocyclic Compounds And Noxious Arthropod Control Agent Containing SameSUMITOMO CHEMICALDec 20, 2023
EP3471766
Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Infectious Bursal Disease Virus AntigensINTERVETSep 12, 2023
EP2833908
Mycoplasma Hyopneumoniae VaccineZOETISOct 3, 2022
EP2970916
Adapted Lepidopteran Insect Cells For The Production Of Recombinant ProteinsMERCK SHARP & DOHMEJan 14, 2022
EP2994162
Vaccine For Pcv2 And MycoplasmaPHARMGATE BIOLOGICSJan 7, 2022

Latest patents of Boehringer Ingelheim Vetmedica Gmbh opposed by its competitors

Explore Boehringer Ingelheim Vetmedica Gmbh's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2488145
Apr 24, 2024Containers For Compositions Comprising Meloxicam1
EP3862003
Oct 25, 2023An Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Disorder In Feline Animals1
EP3485890
May 10, 2023Treatment Of Metabolic Disorders In Canine Animals1
EP3534939
Feb 22, 2023Vaccine Against Porcine Parvovirus And Porcine Reproductive And Respiratory Syndrome Virus And Methods Of Production Thereof1
EP3344289
Jan 29, 2020Pestivirus Vaccines For Congenital Tremors1
EP1951227
Apr 12, 2017Use Of Pde Iii Inhibitors Or Calcium Sensitizers For The Treatment Of Asymptomatic (Occult) Heart Failure1

Latest PTAB cases involving Boehringer Ingelheim Vetmedica Gmbh

Discover the latest PTAB cases involving Boehringer Ingelheim Vetmedica Gmbh, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 27, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Boehringer Ingelheim Vetmedica Gmbh

IPR2019-00374Nov 30, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICA GMBHInstitution Denied
IPR2019-00381Nov 30, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICA GMBHTerminated-Settled
IPR2018-01788Sep 24, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICA GMBHInstitution Denied
IPR2018-01789Sep 24, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICA GMBHInstitution Denied

Peer Comparison New

IP litigation analysis comparing Boehringer Ingelheim Vetmedica Gmbh with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BOEHRINGER INGELHEIM3318789
INTERVET124341
VIRBAC17 - - 1
ZOETIS SERVICES417 - -